Back
Adial Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
32
ADIL
Adial Pharmaceuticals
Last Price:
1.02
Seasonality Move:
-7.51%
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
0.73
Seasonality Move:
-18.64%
Sell
32
Adial Pharmaceuticals (ADIL)
is a Sell
Is Adial Pharmaceuticals a Buy, Sell or Hold?
- The current Adial Pharmaceuticals [ADIL] share price is $1.00. The Score for ADIL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ADIL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.69. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADIL Stock Price Chart
What is Adial Pharmaceuticals's stock price today?
-
The Adial Pharmaceuticals share price today is $1.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADIL is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.69
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADIL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 43.03 | Sell |
Chaikin Money Flow: | -77046 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.99 - 1.07) | Sell |
Bollinger Bands (100): | (0.97 - 1.33) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 56.21 | Buy |
Chaikin Money Flow: | 8668 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ADIL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.05 | Sell |
20-day SMA: | 1.04 | Sell |
50-day SMA: | 1.03 | Sell |
200-day SMA: | 1.38 | Sell |
8-day EMA: | 1.04 | Sell |
20-day EMA: | 1.04 | Sell |
50-day EMA: | 1.06 | Sell |
200-day EMA: | 1.91 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Buy |
20-day SMA: | 0.53 | Buy |
50-day SMA: | 0.74 | Sell |
200-day SMA: | 3.6 | Sell |
8-day EMA: | 0.63 | Buy |
20-day EMA: | 0.59 | Buy |
50-day EMA: | 0.92 | Sell |
200-day EMA: | 8.04 | Sell |
Adial Pharmaceuticals Earnings Growth & ADIL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.73 per share, an increase next quarter of $0.02 per share, an increase this year of $1.70 per share, and an increase next year of $1.54 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Adial Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |